Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.
Seems ERP are now parallel trading with both 0575 and 02945 tickers.
Not that it makes any difference on market cap....lol
bothwell,
i think the reason was because rpg (at the time) had no idea what they were doing. especially after their **** up and amateurism shown regarding can size. since ple were the ones who had obtained the approval for the 20 dose can back in 2013, they had the responsibility of first launch before the sunset date 3 years later in 2016. if you happen to remember. the lock in only happened 3 days before that sunset date (nov 2016) which was because ple had forgotten to agree a can price point with recordati and so had to go with the 20 dose can at the last minute (they could put whatever price they wanted for that as i'm sure it wouldn't impact recordati's own endeavors. i'm sure partly because of this, they were stuck with some small online doctors/pharmacy to make the initial roll out and wanted to leave it all with recordati. there was no way they had the experience or knowhow to take it further and recordati were far too busy sorting out their own list of launches - see below. the result was that the uk was left in the lurch, although i'm sure stocks were changed out for the 12 dose can when they became available, but other than that it was left to its own devices.
recordati's initial responsibility was the e5 followed by a few others as per the nov 2016 announcement...the first batch of fortacin will be on commercial sale, by prescription, in the uk from today. thereafter, regent pacific’s commercial partner recordati s.p.a. is expected to begin sales of fortacin™ in italy, spain, france, germany, portugal (e5), czech republic, slovakia, poland, ireland, romania and greece in 2017.
the uk never even left the starting gate and still hasn't. quite incredible given it was one of the top 3 economies in the eu at the time (portugal and spain were never really players to begin with) so should have been more of a priority, but who knows how the contract was written between rpg/ple and recordati.
the rest is history with the impact of manufacturing problems, which again, rpg should have stepped in years ago to sort out but never did.
lest hope with the otc recordati can pull things together, although at 30k cans/quarter, its going to take a long long time.
if there is anything wrong with the above...tough shti...its all in the past now and depressing to think about......lol
incompetence rules ok........lol
Morning The.Italian,
I've just watched the last 30mins of the FUM Investor seminar, particularly where John Connolly is talking about Boots who he stated are now above the NHS wrt sales.
So If that is indeed the case, why haven't Recordati also approached boots for an agreement. It surely would be an ideal complement with Eroxon.
Prof, yes sorry to see you go after so many years.
Far be it for me to advise but, could it not be prudent to wait till the China submission news (due any week after the end of June)? You could then jump out on a possible spike and be able to buy yourself a puncture repair kit too.... :-)
Or even take a look over at FUM. They seem to have gotten their act together and just received FDA OTC approval for their ED Gel which appears already to be selling well in the UK and Belgium (it has absolutely no side effects). You wont necessarily recoup all your losses, but you could consider jumping in and out and buying a bike with 29"wheels instead of the usual 26". :-)
Anyway, good luck with whatever you decide to do.
I appear to have posted 2 similar posts. They are not showing on my PLE BB with first not even being posted as I performed a refresh, hence the writing of 2. What to write other than LSE still seems to be a bit temperamental.
Yesterday it also dropped early on only to finish in positive territory by close. Maybe the same will happen again today.
1.5mill for both the uk and Belgium (67mill and 11.7mill populations respectively) is quite good for just 2 months. Remember the response to the FDA approval RNS, the sp hardly moved. Whodunnit have guessed.
This is a money maker in the making. With a little time, it will start to gain traction. That said, one would have thought they would have had a US licensee waiting at the gates ready for the off which doesn’t appear to be the case.
Just remember it also dropped 4.5% yesterday too, so although it could be considered as fairly good news, there will always be sellers, particularly after the recent increases. I’m going to make a guess that it will possibly gain later in the day once the %traders have finished. But I have been known to be wrong….lol
Not sure what to make of the FUM RNS. 1.5mill seems Low, however. I expect it’s all from boots sales in the UK, which started only a few months ago which could mean 1.5mill is good going. What do you think?
Morning The.Italian. I’m sure they won’t rock the boat since they will have to have ticked the box JM YES men…..lol
HKRX closed today and tomorrow due to the dragon boat festival.
Well, there was an announcement although the subject not what i was expecting.
Now what....
BDO has confirmed in its resignation letter to the Company and the audit committee of the
Company (the ‘‘Audit Committee’’) that there are no matters in respect of its resignation that
need to be brought to the attention of the shareholders of the Company (the ‘‘Shareholders’’).
Although no reason given, I expect they have thrown in the towel because they are fed up waiting for some real accounts they can get their teeth into. Rather than the usual jiggery pokery to try and make the accounts look decent. Certainly could indicate they are not expecting any injection of money anytime soon. Just speculation on my part, but usually accounting companies don't resign a few days before the mid year interim results coming up without some reason.
And ???
I think given the FDA approval. the trend is now upwards. Yes, profit taking in the morning, but up again in positive territory once the sellers have taken their 10%....lol
Up 4.5% on no volume, could this mean M&Ms have access to some news. Interesting to see if there is any announcement this evening.
Morning The.Italian,
Obviously that was about yesterday, although maybe today too ? :-)
Nice to see FUM having a good day. Volume up as is the sp. Long may it continue. A lot of catching up to do here. ;-)
Morning The.Italian.
I wouldn’t underestimate their lack of communication since we have witnessed many times them failing to update the market/shareholders. They follow absolutely no fiduciary requirements.
They just need to get an agreement with 7-Eleven who have outlets all over the globe (In 2001, there were over 72,000 stores in the world). Obviously local approvals will be needed, however. Get an agreement with 7-Eleven Inc and let them follow up with relevant approval processes. They can then place the product next to the Durex stands they currently have near the counters. They must have some agreement with Durex or whoever holds the license.
Of course that's me being pessimistic re the FDA and License agreement which is based on them taking 9 years to get this far. 5 years of which have been spent towards phase III. There is noting to say they may get a lifeline within the next 6 months, but I choose not to count on it as we have been thoroughly let down many times before.
Note: Even though have ref'd they have been in discussions with a Japanese licensee the last couple of years, I am sure they too will be waiting on an FDA result.
Onwards and sideways.
Morning The.Italian,
I’m afraid I am not suggesting China will negate the need for yet another cash call since no monies will be forthcoming until the approval next year.
Since there won’t be anything coming from the US or even the EU (30k cans every 4 months won’t cut it), I expect that Jim will have to sub the company since there isn’t any money after Dec. I don’t see him subbing the phase iii but only the operating costs for both ERP and the DLI. I have no idea if the FDA have time limits between the end of phase II and the commencement of phase iii.